Introdução: Dirofilariose é uma zoonose rara causada pelo gênero Dirofilaria e acomete principalmente os pulmões, sendo capaz de simular neoplasia pulmonar. Pouca informação está disponível na literatura sobre a ocorrência e a distribuição de dirofilariose humana na América do Sul. Até 2004, haviam sido descritos apenas 50 casos de dirofilariose humana pulmonar no Brasil, sendo 37 apenas em São Paulo. Objetivo: Comprovar a existência de dirofilariose na região de Joinville-SC. Materiais e métodos: Revisão de arquivos de laboratórios de anatomia patológica da cidade à procura de casos com os termos granuloma parasitário, helminto, helmintíase, verme, Dirofilaria e dirofilariose. Foram incluídos na pesquisa casos que satisfizeram os critérios para dirofilariose, segundo literatura específica. Os prontuários foram revisados e as amostras reprocessadas e analisadas histologicamente por seis colorações diferentes. Resultados: Encontrou-se um caso em globo ocular e sete casos pulmonares, sendo o lobo inferior a localização preferencial (cinco casos). A análise microscópica revelou, nos casos pulmonares, nódulo bem delimitado, frequentemente centrado em uma artéria, com reação granulomatosa e necrose associada à fibrose e infiltrado inflamatório mono e polimorfonuclear, sendo possível identificar segmentos do parasita degenerado, compatível
Pemphigus vulgaris (PV) is a rare mucocutaneous disease caused by the abnormal production of antibodies against epithelial cell surface glycoproteins, resulting in loss of cell adhesion and intraepithelial blister formation. Cervical involvement in PV has been poorly reported, and there is little information regarding the criteria about consequential cytological changes identified in a Papanicolaou-stained cervicovaginal smear (Pap smear). Here, we report a case of PV manifesting in the cervix as well as the difficulty associated with the cytomorphological identification and interpretation of acantholytic cells. This case involved a 40-year-old patient with no history of Pap test abnormalities and no prior diagnosis of PV. In the cytological assessment, cells were identified both in isolation and in clusters that exhibited round nuclei of increased volume, inconspicuous nucleoli, and perinuclear halos. The patient underwent a cervical biopsy that revealed vesiculobullous lesions and morphological pattern consistent with PV. A skin biopsy confirmed this diagnosis. We concluded that knowledge of PV cytomorphology is important because difficulties associated with the identification and interpretation of acantholytic cells might be responsible for false positive diagnoses of cervical neoplasia. However, a suspected diagnosis of PV is possible if the cytological findings are carefully correlated with the clinical data.
Repeat FNA is a valuable procedure in cases with initial non-diagnostic or A/FLUS cytology, but its routine use for patients with an initial benign examination appears to not increase the expected likelihood of a malignant finding.
The Epstein–Barr virus (EBV)-positive mucocutaneous ulcer is a rare entity in the spectrum of lymphoproliferative diseases associated with the EBV. It occurs typically in patients with immunosuppression associated with immunosenescence, as well as due to iatrogenic causes, posttransplant patients and primary immunodeficiency disorders. It is often a benign and self-limited disease that recedes by stopping or reducing the immunosuppressive agents in most of the cases. Histologically, it is characterized by a population of EBV-positive atypical lymphoid cells. Here, we present a rare case of a 5-month-old pediatric patient, born preterm at 24 weeks of gestational age, presenting a lump on the right shoulder, later evolving to EBV-positive mucocutaneous ulcer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.